Beltran, Pedro External Entity

Publications

Sort by

Selected publications

  • Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.  Targeted oncology2015 Academic Article GET IT
    Times cited: 8

Other